Cholestatic hepatitis ascribed to the use of thiabendazol;Cholestatische hepatitis toegeschreven aan her gebruik van tiabendazol

Nederlands Tijdschrift voor Geneeskunde

Volumn 142, Issue 23, 1998, Pages 1331-1334

  Eland, I A ^a   Kerkhof, S C M B ^a   Overbosch, D ^b   Wismans, P J ^b   Stricker, B H Ch ^a,c  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b Havenziekenhuis   (Netherlands)

^c Sectie Geneesmiddelenbewaking   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

TIABENDAZOLE; ANTHELMINTIC AGENT;

ADULT; ARTICLE; CASE REPORT; CHOLESTATIC HEPATITIS; ECHOGRAPHY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEMALE; HUMAN; LIVER FUNCTION; STRONGYLOIDIASIS; ETHNOLOGY; NETHERLANDS; SURINAME; TOXIC HEPATITIS;

ADULT; ANTHELMINTICS; FEMALE; HEPATITIS, CHRONIC, DRUG-INDUCED; HUMANS; NETHERLANDS; STRONGYLOIDIASIS; SURINAME; THIABENDAZOLE;

EID: 0032490158     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Evaluation of a broad-spectrum anthelmintic thiabendazole (Mintezol). JAMA 1968;205:172-3.
2. Grove DI. Treatment of strongyloidiasis with thiabendazole: an analysis of toxicity and effectiveness. Trans R Soc Trop Med Hyg 1982;76:114-8.
3. Hennekeuser HH, Pabst K, Poeplau W, Gerok W. Thiabendazole for the treatment of trichinosis in humans. Tex Rep Biol Med 1969:27 Suppl 2:581-96.
4. Bayles MA. Chromomycosis. Treatment with thiabendazole. Arch Dermatol 1971;104:476-85.
5. Jalota R, Freston JW. Severe intrahepatic cholestasis due to thiabendazole Am J Trop Med Hyg 1974;23:676-8.
6. Bloomer JR, Boyer JL. Phenobarbital effects in cholestatic liver diseases. Ann Intern Med 1975;82:310-7.
7. Fink AI, MacKay CJ, Cutler SS. Sicca complex and cholangiostatic jaundice in two members of a family probably caused by thiabendazole. Ophthalmology 1979;86:1892-6.
8. Rex D, Lumeng L, Eble J, Rex L. Intrahepatic cholestasis and sicca complex after thiabendazole. Report of a case and review of the literature. Gastroenterology 1983;85:718-21.
9. Manivel JC, Bloomer JR, Snover DC. Progressive bile duct injury after thiabendazole administration. Gastroenterology 1987;93: 245-9
10. Davidson RN, Weir WR, Kaye GL, McIntyre N. Intrahepatic cholestasis after thiabendazole. Trans R Soc Trop Med Hyg 1988, 82:620.
11. Roy MA, Nugent FW, Aretz HT. Micronodular cirrhosis after thiabendazole. Dig Dis Sci 1989;34:938-41.
12. Bion E, Pariente EA, Maitre F. Severe cholestasis and sicca syndrome after thiabendazole [letter]. J Hepatol 1995;23:762-3
13. Stricker BHC. Drug-induced hepatic injury. 2nd ed. Amsterdam: Elsevier, 1992.
14. Seitz R, Schwerk W, Arnold R. Hepatozellulare Arzneimittelreaktion unter Mebendazoltherapie bei Echinococcus cysticus. Z Gastroenterol 1983;21:324-9.
15. Junge U, Mohr W. Mebendazol-Hepatitis. Z Gastroenterol 1983;21: 736-8.
16. Morris DL, Smith PG. Albendazole in hydatid disease - hepatocellular toxicity. Trans R Soc Trop Med Hyg 1987;81:343-4.
17. Bekhti A, Pirotte J Hepatotoxicity of mebendazole. Relationship with serum concentrations of the drug. Gastroenterol Clin Biol 1987; 11:701-3.
18. Duh MS, Walker AM, Kronlund K. Descriptive epidemiology of acute liver disease in the general population of central Massachusetts Pharmacoepidemiology and Drug Safety 1997;6 Suppl 2:S14.